HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Balraj Mittal Selected Research

Gallstones (Gallstone)

6/2014Association of genetic variants of xenobiotic and estrogen metabolism pathway (CYP1A1 and CYP1B1) with gallbladder cancer susceptibility.
12/2013Association of liver X receptors (LXRs) genetic variants to gallbladder cancer susceptibility.
6/2013Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus.
1/2013Multi-analytic approach elucidates significant role of hormonal and hepatocanalicular transporter genetic variants in gallstone disease in North Indian population.
9/2012Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
1/2011Organic anion transporter 1B1 (SLCO1B1) polymorphism and gallstone formation: High incidence of Exon4 CA genotype in female patients in North India.
8/2010Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population.
6/2010CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population.
7/2009Single nucleotide polymorphism in the ABCG8 transporter gene is associated with gallbladder cancer susceptibility.
1/2009Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Balraj Mittal Research Topics

Disease

55Neoplasms (Cancer)
07/2019 - 01/2002
31Gallbladder Neoplasms (Gallbladder Cancer)
01/2020 - 02/2004
18Carcinogenesis
11/2014 - 01/2007
18Gallstones (Gallstone)
06/2014 - 02/2004
16Esophageal Neoplasms (Esophageal Cancer)
01/2014 - 01/2007
14Cholelithiasis
06/2013 - 08/2004
12Obesity
09/2018 - 05/2008
12Stomach Neoplasms (Stomach Cancer)
11/2014 - 01/2009
9Genetic Predisposition to Disease (Genetic Predisposition)
01/2018 - 06/2008
9Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2017 - 01/2008
9Breast Neoplasms (Breast Cancer)
01/2016 - 01/2013
7Insulin Resistance
09/2018 - 11/2011
7Epilepsy (Aura)
06/2013 - 08/2009
6Dyspepsia (Indigestion)
09/2017 - 11/2007
6Inflammation (Inflammations)
09/2017 - 01/2008
6Migraine Disorders (Migraine)
11/2013 - 01/2010
5Body Weight (Weight, Body)
04/2016 - 07/2002
5Infections
04/2014 - 11/2007
5Carcinoma (Carcinomatosis)
01/2014 - 02/2004
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2017 - 01/2008
4Esophageal Squamous Cell Carcinoma
11/2014 - 01/2010
4Lung Neoplasms (Lung Cancer)
01/2013 - 10/2009
4Neoplasm Metastasis (Metastasis)
01/2013 - 01/2008
4Gastritis
07/2010 - 03/2008
3Rheumatic Heart Disease (Rheumatic Heart Diseases)
01/2020 - 10/2013
3Urinary Bladder Neoplasms (Bladder Cancer)
04/2016 - 08/2005
3Type 2 Diabetes Mellitus (MODY)
01/2015 - 02/2007
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2015 - 01/2010
3Heart Failure
01/2014 - 01/2011
3Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
09/2013 - 03/2012
3Chronic Obstructive Pulmonary Disease (COPD)
01/2013 - 06/2011
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2012 - 10/2006
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2010 - 10/2009
3Microsatellite Instability
04/2004 - 01/2002
2Neutropenia
10/2015 - 06/2014
2Left Ventricular Dysfunction
05/2015 - 01/2011
2Anemia
06/2014 - 12/2013
2Morbid Obesity
03/2014 - 07/2012
2Lactose Intolerance (Intolerance, Lactose)
09/2013 - 12/2012
2Hypertension (High Blood Pressure)
05/2013 - 07/2005
2Ischemic Stroke
05/2013 - 01/2011
2Atherosclerosis
05/2013 - 01/2011

Drug/Important Bio-Agent (IBA)

21EnzymesIBA
01/2016 - 09/2006
13Proteins (Proteins, Gene)FDA Link
11/2017 - 07/2005
12CholesterolIBA
06/2013 - 01/2004
10DNA (Deoxyribonucleic Acid)IBA
05/2014 - 11/2002
8CytokinesIBA
01/2018 - 01/2007
8LipidsIBA
12/2013 - 01/2004
7MicroRNAs (MicroRNA)IBA
09/2017 - 08/2010
7ApolipoproteinsIBA
05/2016 - 02/2004
7Pharmaceutical PreparationsIBA
01/2016 - 08/2009
7Matrix Metalloproteinases (MMPs)IBA
09/2014 - 07/2008
6Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2013
6XenobioticsIBA
07/2014 - 07/2008
5Insulin (Novolin)FDA Link
01/2017 - 11/2011
5Apolipoproteins E (ApoE)IBA
05/2016 - 07/2005
5TeaIBA
11/2014 - 07/2009
5Estrogens (Estrogen)FDA Link
07/2014 - 01/2012
4Interleukin-10 (Interleukin 10)IBA
09/2017 - 01/2007
4Biological ProductsIBA
01/2017 - 04/2004
4Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2015 - 04/2008
4phospholipase C epsilonIBA
11/2014 - 12/2013
4Cytochrome P-450 CYP1A1 (CYP1A1)IBA
06/2014 - 01/2007
4CarcinogensIBA
04/2014 - 01/2005
4Glutathione Transferase (Glutathione S-Transferase)IBA
12/2013 - 01/2005
4Immunoglobulin G (IgG)IBA
08/2012 - 11/2007
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2010 - 01/2009
3NucleotidesIBA
09/2017 - 09/2011
3AdiponectinIBA
01/2017 - 04/2013
3Genetic Markers (Genetic Marker)IBA
02/2016 - 11/2002
3Hormones (Hormone)IBA
01/2015 - 06/2014
3Environmental CarcinogensIBA
06/2014 - 07/2009
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2013 - 08/2010
3Epoxide HydrolasesIBA
07/2013 - 07/2008
3Apolipoproteins B (ApoB)IBA
01/2013 - 02/2004
3NRH - quinone oxidoreductase2IBA
12/2012 - 05/2011
3Toll-Like Receptors (Toll-Like Receptor)IBA
10/2011 - 09/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2010 - 03/2008
3gamma-Aminobutyric Acid (GABA)IBA
05/2010 - 07/2002
3UreaseIBA
06/2009 - 11/2007
3Interleukin-6 (Interleukin 6)IBA
01/2009 - 10/2007
3Epidermal Growth Factor (EGF)IBA
06/2008 - 10/2007
3Indicators and Reagents (Reagents)IBA
07/2004 - 01/2003
23' Untranslated Regions (3' UTR)IBA
12/2016 - 01/2007
2Cardiac MyosinsIBA
06/2016 - 01/2011
2Carrier Proteins (Binding Protein)IBA
06/2016 - 01/2011
2Agouti-Related ProteinIBA
05/2016 - 03/2014
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
05/2016 - 03/2014
2AntigensIBA
02/2016 - 08/2012
2O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA
01/2016 - 01/2005
2Angiotensin IIIBA
05/2015 - 08/2010
2ProgesteroneFDA LinkGeneric
07/2014 - 01/2012
2Adrenergic Receptors (Adrenergic Receptor)IBA
05/2014 - 01/2014
2Phospholipases (Phospholipase)IBA
01/2014 - 12/2013
2Triglycerides (Triacylglycerol)IBA
04/2013 - 08/2012
2Tissue Inhibitor of MetalloproteinasesIBA
01/2013 - 09/2012

Therapy/Procedure

12Drug Therapy (Chemotherapy)
01/2016 - 10/2007
10Therapeutics
10/2018 - 01/2003
5Adjuvant Chemotherapy
06/2016 - 01/2013
2Radiotherapy
10/2015 - 10/2007